Anne Melissa Dowling, Former Commissioner of Insurance for Illinois and Connecticut, will succeed Tom Wamberg as Chairperson of healthŌme’s Board of Directors
HUNTSVILLE, ALA., Feb. 27, 2023 – healthŌme™ Inc., an Ōmics-based health navigation company and HudsonAlpha Institute for Biotechnology associate company, announced today the appointment of Anne Melissa Dowling, CFA, a seasoned insurance industry executive, as the Chairperson to the company’s Board of Directors, effective immediately. She will succeed the former Executive Chairman of the board, Tom Wamberg, who has left the organization.
Dowling’s unique experience as an insurance regulator, investment executive, and board member or advisor to multiple insurance and insurtech companies makes her uniquely qualified to guide healthŌme’s efforts to drive the use of insurance-based financial vehicles to accelerate access to precision medicine. healthŌme is dedicated to simplifying and accelerating access to technologies and services that can dramatically alter an individual’s health trajectory, with an initial focus on cancer. The company designs, develops, and delivers its innovative health management solutions through a network of life and critical insurance carriers. Dowling joined healthŌme’s Board of Directors in August 2021, and in addition, she continues to serve in a number of board governance and senior advisory roles for Bain Capital Insurance (NYSE: BCSF), Axis Capital (NYSE: AXS), Prosperity Life Insurance Group, and Keystone Agency Partners.
“We are thrilled to announce the appointment of Anne Melissa Dowling as our new Chairperson as she was a natural fit for the role,” said Darren Rowe, CEO of healthŌme. “With Anne Melissa’s extraordinary experience leading in both the public and private sectors, success in modernizing the insurance industry, and passion for providing access to better health management, I am confident that she will play a crucial role in navigating the company toward success in expediting access to new technologies that challenge the way precision healthcare is accessed, financed, and delivered.”
“I am thrilled to provide leadership to healthŌme’s team and contribute to the Company’s vision to create an environment where every individual’s healthcare experiences are informed and elevated by their unique biological data and supported through deep human connection”, said Dowling. “I look forward to working with the Board of Directors and healthŌme’s team to continue driving innovation in the insurance industry.”
Over her career, Ms. Dowling has served in the public sector as the Director of the Illinois Department of Insurance, and the Acting Commissioner and Commissioner of Insurance for the Connecticut Insurance Department. In the corporate sector, she held Senior Vice President roles for Massachusetts Mutual (MMG) where she grew the Institutional Insurance Division from startup to $13 billion in assets under management. Prior to that success, she was the Chief Investment Officer at Connecticut Mutual and the Senior Vice President Director of International Investment at Travelers.
Dowling has served on multiple non-profit and educational boards of trustees and continues her service currently as a Tour Guide for students at The Metropolitan Museum of Art. She is a Chartered Financial Analyst (CFA) and holds an M.B.A. from Columbia University School of Business and a B.A. from Amherst College.
healthŌme™ is an Ōmics-based health navigation company dedicated to simplifying and accelerating access to technologies and services that can dramatically alter an individual’s health trajectory, with an initial focus on cancer. Based at the HudsonAlpha Institute for Biotechnology in Huntsville, Alabama, healthŌme, in partnership with Hannover Re US, designs, develops, and delivers its innovative health management solutions through a network of life and critical insurance carriers. Additional information can be found at: www.healthome.com.